StocksInsight

ARMK Stock vs the S&P 500: Returns, Risk and Crash History

Aramark, industrials (market value $15.0 billion): how it compared with the S&P 500, how it behaved in every crash since 2008, its risk‑adjusted returns and what analysts said. Returns to Oct 30, 2026; analyst data as of Nov 16, 2026.

Published Updated 4 min readHow we research

Key takeaways

  • ARMK returned +117.1% over the 5 years to Oct 30, 2026 versus +75.9% for the S&P 500: it beat the index.
  • Its 5-year Sharpe ratio was 0.57 against 0.58 for the S&P 500.
  • Its deepest crisis drawdown was −69.8% in the covid crash (feb–mar 2020) (S&P 500: −34.1%).
  • Five‑year volatility was 28.8% and beta 1.10.
  • 13 analysts rated it in the past year; 92% of their latest calls were Buy.
  • ARMK beat earnings estimates in 9 of its last 12 reports; the stock moved 5.7% on average, up or down, around each report.

What do the best‑ranked analysts on ARMK say now? See it in Exent Gems →

Did ARMK beat the S&P 500?

Over the 5 years to Oct 30, 2026, Aramark (ARMK) returned +117.1% including dividends, versus +75.9% for the S&P 500 (SPY). It beat the index by 41.2 percentage points, or +16.8% a year against +12.0%.

PeriodARMKS&P 500ARMK per yearS&P 500 per yearResult
1 year+44.0%+12.0%+44.0%+12.0%Beat
3 years+107.1%+87.4%+27.5%+23.3%Beat
5 years+117.1%+75.9%+16.8%+12.0%Beat
10 years+126.0%+316.3%+8.5%+15.3%Lagged
  • 1 year
    ARMK
    +44.0%
    S&P 500
    +12.0%
    ARMK per year
    +44.0%
    S&P 500 per year
    +12.0%
    Result
    Beat
  • 3 years
    ARMK
    +107.1%
    S&P 500
    +87.4%
    ARMK per year
    +27.5%
    S&P 500 per year
    +23.3%
    Result
    Beat
  • 5 years
    ARMK
    +117.1%
    S&P 500
    +75.9%
    ARMK per year
    +16.8%
    S&P 500 per year
    +12.0%
    Result
    Beat
  • 10 years
    ARMK
    +126.0%
    S&P 500
    +316.3%
    ARMK per year
    +8.5%
    S&P 500 per year
    +15.3%
    Result
    Lagged

Total return with dividends reinvested, from month-end prices to Oct 30, 2026. Beating the index on raw return is only half the story: the next section adjusts for the risk taken. See also how to beat the S&P 500.

What Wall Street analysts say about ARMK

In the 12 months to 30 days ago, 13 analysts published 138 ratings on ARMK. Their latest calls were 92% Buy, 8% Hold and 0% Sell. 3 of them rank 4★ or higher in Exent’s analyst scoring, which is based on each analyst’s past price‑target hit rate and returns.

The consensus 12‑month price target was $68.64 (range $63.00–$74.00), +20.7% from the last price. Remember that the average analyst’s target is hit only about half the time: how accurate are price targets?

Top‑ranked analyst coveringFirmStarsPrice‑target hit rate
??????4.9★54.1%
Stephanie MooreJefferies4.9★55.4%
Ian ZaffinoOppenheimer4.6★41.1%

Ratings are shown with a 30‑day delay. Who the top‑ranked analysts on ARMK are, their live calls and the median target of only the top‑rated analysts are in Exent Gems.

The average analyst’s target is reached about 53.0% of the time; Exent Gems is built on the top 50 of Exent’s ranking,where some reached 90% or more over the last two years. Unlock the top 50 analysts.

ARMK returns by year vs the S&P 500

ARMK beat the S&P 500 in 3 of the 9 full calendar years shown.

YearARMKS&P 500Difference
2026 (to Oct 30, 2026)+47.5%+11.7%+35.8%
2025−0.1%+17.7%−17.8%
2024+34.2%+24.9%+9.3%
2023−4.6%+26.2%−30.8%
2022+13.5%−18.2%+31.7%
2021−3.0%+28.7%−31.7%
2020−10.0%+18.3%−28.3%
2019+51.7%+31.2%+20.5%
2018−31.5%−4.6%−26.9%
2017+20.9%+21.7%−0.8%

ARMK risk-adjusted returns: Sharpe, Sortino and volatility

Over 5 years, ARMK had a Sharpe ratio of 0.57 against 0.58 for the S&P 500, so it earned less return per unit of risk than the index. Its annualized volatility was 27.0% and its beta 1.10: it tended to move about 1.1× as much as the market.

MetricARMKS&P 500
Annual return+16.8%+12.0%
Volatility (annualized)27.0%15.5%
Sharpe ratio0.570.58
Sortino ratio0.990.91
Max drawdown (month-end)−21.8%−23.9%
Beta to the S&P 5001.101.00

Sharpe divides return above cash by total volatility; Sortino counts only downside volatility. Both use monthly returns and the 1–3 month T‑bill ETF (BIL) as the risk‑free rate.

How ARMK behaved in past crashes

ARMK’s deepest fall in the crises below was −69.8% in the covid crash (feb–mar 2020), against −34.1% for the S&P 500. The last column turns that into money: what a $100,000 position would have lost from peak to trough.

CrisisARMKS&P 500Loss on $100,000
2018 trade-war selloff−36.3%−20.2%−$36,300
COVID crash (Feb–Mar 2020)−69.8%−34.1%−$69,810
2022 inflation bear market−25.0%−25.4%−$25,020
2025 tariff selloff−18.2%−19.0%−$18,240
WindowARMK max drawdown
Last 1 year−19.2%
Last 3 years−27.7%
Last 5 years−27.7%
Last 10 years−72.3%

Peak‑to‑trough declines from daily prices inside each crisis window. A crash replay does not predict the next crisis; it shows how much room a holding needs. Run the same replay on a whole portfolio with the crash test.

What moves with ARMK, and what doesn’t

Correlation runs from −1 (moves opposite) to +1 (moves in lockstep). Over the last 60 months of monthly returns, ARMK’s correlation with the S&P 500 was 0.63, with the Nasdaq‑100 0.54, with long Treasuries (TLT) 0.25 and with gold (GLD) 0.11.

Adding a 5% ARMK position to an S&P 500 portfolio would have moved its 5‑year volatility from 15.5% to 15.6%.

Least correlated large capsCorrelationMost correlated large capsCorrelation
REGN−0.18CSX0.65
PFE−0.02CSCO0.60
ABBV−0.01GE0.57
CME0.04RCL0.56
XOM0.06MAR0.56

Holdings that are highly correlated behave like one position in a selloff. See how to find hidden overlap.

Latest ARMK upgrades, downgrades and price‑target changes

DateRating and targetAnalyst
Oct 12Target raised
Buy
Target $75.50, was $74
Leo Carrington
Citi

Named analysts’ rating and price‑target changes on ARMK in the 5 weeks to Oct 20, 2026, shown 30 days after publication (the free analysts’ calls 3 days after). The top‑ranked analysts’ calls are in Exent Gems. See all of the latest analyst upgrades and downgrades.

How ARMK moves after earnings

ARMK beat the consensus earnings‑per‑share estimate in 9 of its last 12 quarterly reports, through the one on Aug 11, 2026, and the revenue estimate in 6 of 12. From the close before each report to the close after it, the stock moved 5.7% on average, up or down, against 6.8% for the average report across the 1,002 US stocks Exent tracks. It rose after 6 of the 12 reports. In 3 of the 9 beats the stock still fell.

9/12earnings beats
±5.7%average move per report
6/12reports followed by a rise
ReportEPS vs estimateRevenue vs estimateStock move
Aug 11, 2026$0.52 vs $0.48+1.8%+8.3%
May 12, 2026$0.49 vs $0.47+1.1%+13.9%
Feb 10, 2026$0.51 vs $0.50+2.0%+8.8%
Nov 17, 2025$0.64 vs $0.64−2.2%−3.6%
Aug 5, 2025$0.40 vs $0.40−10.5%−8.4%
May 6, 2025$0.34 vs $0.33−8.4%+11.8%
Feb 4, 2025$0.51 vs $0.48+4.4%−1.5%
Nov 11, 2024$0.54 vs $0.53−0.9%−2.8%

Reported earnings per share against the consensus estimate, revenue surprise in percent, and the stock’s price change over the two sessions around the report. How stocks move after earnings

Where ARMK’s revenue comes from

In fiscal 2024 (the year to Sep 27, 2024), ARMK’s largest reported region was the United States, with 71.5% of its $17.4 billion revenue. By region: United States 71.5%; Foreign 28.5%.

By business, the largest segment was Food and Support Services - United States, with 72.3% of $17.4 billion revenue (+7.3% on the year before).

  • United States71.5%
  • Foreign28.5%
SegmentRevenueShareGrowth
Food and Support Services - United States$12.6 billion72.3%+7.3%
Food and Support Services - International$4.8 billion27.7%+10.6%

From ARMK’s annual filings; segment growth compares fiscal 2024 with the year before. Regions are as each company reports them, so one company’s “Asia Pacific” is not another’s. China counts the regions a company reports as China, Greater China or Hong Kong; a separately reported Taiwan is not counted. Which S&P 500 companies depend most on China?

Members of Congress who traded ARMK

As of Oct 20, 2026, 6 members of Congress had disclosed 17 trades in ARMK (11 buys and 6 sales) in STOCK Act disclosures filed with the House and Senate. The latest public trade is dated Jun 18, 2026.

Trade dateMemberTypeAmount
Jun 18, 2026Michael McCaulSale$1,001–$15,000
Dec 10, 2025Gilbert CisnerosBuy$1,001–$15,000
Jun 17, 2025Lisa McClainSale$1,001–$15,000
Jun 11, 2025Lisa McClainBuy$1,001–$15,000
Apr 14, 2025Gilbert CisnerosBuy$1,001–$15,000
Apr 10, 2025Jonathan JacksonSale$15,001–$50,000
Feb 5, 2025William KeatingBuy$1,001–$15,000
Nov 14, 2024Michael McCaulBuy$50,001–$100,000
Sep 20, 2024Michael McCaulBuy$100,001–$250,000
Sep 19, 2024Jonathan JacksonBuy$15,001–$50,000

Amounts are the ranges members report, not exact values. The STOCK Act gives members up to 45 days to disclose a trade, so trades appear weeks after they are made. See every member’s disclosed trades

Are ARMK insiders buying or selling?

In the 12 months to Oct 20, 2026, ARMK insiders made no open‑market purchases and 4 sales worth $5.3 million, according to SEC Form 4 filings. The last open‑market purchase on record was on Aug 7, 2025.

After the 25 insider purchases of $10,000 or more since 2012, ARMK beat the S&P 500 by an average of 8.3 percentage points over the next 12 months; 76% of them were followed by a beat. Across all 17,865 insider purchases in Exent’s study, the average was +17.2% and the median +1.0% against the index.

Q4 ’24
Q1 ’25
Q2 ’25
Q3 ’25
Q4 ’25
Q1 ’26
Q2 ’26
Q3 ’26
DateInsiderRoleValue
Aug 7, 2025Zillmer John JDirector, officer: Chief Executive Officer$249,569
Aug 12, 2022Mantle Ridge LPOther: Director by deputization$207.2 million
Aug 12, 2022Hilal Paul CDirector$383.5 million
May 8, 2020Ondrof Thomas GerardExecutive VP and CFO$249,908
Mar 23, 2020Sadove Stephen IDirector$88,766

The table lists the latest open‑market purchases on record, leaving out the last 30 days. The chart counts Form 4 purchases and sales by calendar quarter. Purchases are open‑market buys; sales include planned sales under 10b5‑1 trading plans. Do insider buys beat the market?

How much of ARMK is sold short?

As of the Sep 30, 2026 settlement date, 2.99% of ARMK’s float was sold short: 7.8 million shares, or 3.6 days of average trading volume to cover. A year earlier (Oct 15, 2025) it was 3.70%. The median across the 997 US stocks Exent tracks was 4.77%, so ARMK is less heavily shorted than most.

  • Apr 30, 20263.69%
  • May 29, 20264.14%
  • Jun 30, 20264.06%
  • Jul 31, 20263.58%
  • Aug 31, 20263.37%
  • Sep 30, 20262.99%

From FINRA short‑interest reports, filed twice a month; the bars show the short share of the float at each month‑end. Days to cover divides the shares short by the average daily volume. The most shorted stocks

How many institutions own ARMK?

At the end of Q2 2026 (Jun 30, 2026), 562 institutions reported holding ARMK in 13F filings, up 82 from the quarter before and up from 380 a year earlier. Their reported holdings add up to 99.6% of ARMK’s shares. In the quarter 317 institutions added to their positions and 164 cut them.

56213F holders
123new positions
47positions closed
99.6%of shares held by 13F filers

Investment managers with over $100 million in US equities file 13F reports within 45 days of each quarter end, so this is the latest complete quarter. Holdings can add up to more than 100% when shares are lent and counted twice. Which stocks institutions are buying and selling

Is ARMK diluting shareholders?

ARMK’s diluted share count rose 6.2% over the five fiscal years to fiscal 2025 and rose 0.4% in fiscal 2025 alone. Each share now owns a smaller slice of the company. The median change across the 1,005 US stocks Exent tracks was −0.1%.

Stock‑based compensation was $58.6 million in fiscal 2025, 0.3% of revenue. ARMK spent $140.2 million buying back shares, a buyback yield of 0.97% of its market value; stock pay equaled 41.8% of the buybacks.

+0.4%share count, 1 year
+6.2%share count, 5 years
0.3%stock pay as % of revenue
0.97%buyback yield

Weighted‑average diluted shares from ARMK’s annual income statements; stock‑based compensation and buybacks from its cash‑flow statement. Stock dilution and stock‑based compensation, explained

ARMK financial health scores

In Exent’s Oct 20, 2026 snapshot, ARMK’s Altman Z‑score was 2.59, in the grey zone (where 149 of the 794 non‑financial US stocks Exent tracks sit). Its Piotroski F‑score was 8 out of 9; 20% of scored stocks reach 8 or more.

2.59Altman Z‑score: grey zone
8/9Piotroski F‑score

The Altman Z‑score combines five balance‑sheet and earnings ratios into one bankruptcy‑risk score: below 1.81 is the distress zone, 1.81–2.99 grey, above 2.99 safe. It is not meaningful for banks, insurers and REITs. The Piotroski F‑score counts nine yes/no tests of profitability, leverage and efficiency; 8–9 is strong, 0–2 weak. Both come from the latest annual statements. Which stocks have the highest bankruptcy risk?

Which ETFs hold ARMK?

As of Oct 20, 2026, 31 of the 304 ETFs Exent tracks held ARMK. Its largest weight is in RFV (Invesco S&P MidCap 400 Pure Value ETF), at 0.89% of the fund.

ETFFundWeight of ARMK
RFVInvesco S&P MidCap 400 Pure Value ETF0.89%
IJHiShares Core S&P Mid-Cap ETF0.44%
SPMDState Street SPDR Portfolio S&P 400 Mid Cap ETF0.43%
MDYState Street SPDR S&P MIDCAP 400 ETF Trust0.43%
CGGRCapital Group Growth ETF0.37%
VBRVanguard Small-Cap Value Index Fund ETF Shares0.32%
SCHMSchwab U.S. Mid-Cap ETF0.31%
DFASDimensional U.S. Small Cap ETF0.21%

Owning several of these funds stacks the same position. How much do VOO, QQQ and VTI overlap?

The right benchmark for ARMK

Exent matches every holding to the index with the most similar risk. For ARMK that is MDY. Comparing a holding with an index that carries very different risk makes good results look bad and risky ones look clever. Read why the S&P 500 is the wrong benchmark for most portfolios.

Other industrials stocks

TickerName5‑year returnVolatility (5y)
SPCXSpace Exploration Technologies Corp.——
GEGE Aerospace+374.0%31.1%
RTXRTX Corporation+150.3%23.8%
TXTTextron Inc.+16.6%27.5%
CLHClean Harbors, Inc.+168.5%28.4%
MLIMueller Industries, Inc.+343.6%32.7%
LECOLincoln Electric Holdings, Inc.+109.2%26.4%
GGGGraco Inc.−4.3%24.0%

Data and methodology

Returns are total returns from month‑end adjusted closing prices (dividends reinvested) through Oct 30, 2026. Crisis drawdowns and trailing maximum drawdowns use daily prices. Analyst coverage counts ratings published in the last 12 months, shown with a 30‑day delay. Full method: Exent methodology.

Company data as of Oct 20, 2026. The move around an earnings report runs from the close before it to the close after it; a price target counts as hit when the stock closed at or beyond it within 12 months (Exent analyst data). Revenue by region and segment, share counts and executive pay come from company filings; insider trades from SEC Form 4, short interest from FINRA, institutional ownership from 13F filings, Congress trades from STOCK Act disclosures filed with the House and Senate, federal contracts from USAspending.gov. Filings from the last 30 days are shown as counts only.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Check ARMK with Exent Gems

Wall Street’s average ARMK price target is 20.7% above the latest share price. See what the best‑ranked analysts on ARMK say now in Exent Gems.

  1. Exent ranks Wall Street analysts by their past price‑target hit rate and returns, and keeps the best‑ranked few.
  2. Gems shows who the top‑ranked analysts covering ARMK are, their live calls and the median target of only the top‑rated analysts.
  3. Gems flags the stocks where several top‑ranked analysts agree: a starting point for your own research, not a promise.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

No. ARMK returned +126.0% (+8.5% a year) over the 10 years to Oct 30, 2026, versus +316.3% (+15.3% a year) for the S&P 500, including dividends.

No. As of Oct 20, 2026, ARMK (Aramark) is not one of the 503 stocks in the S&P 500.

ARMK fell −69.8% from peak to trough during the covid crash (feb–mar 2020), versus −34.1% for the S&P 500.

ARMK fell −25.0% from peak to trough during the 2022 inflation bear market, versus −25.4% for the S&P 500.

Over the 5 years to Oct 30, 2026, ARMK’s Sharpe ratio was 0.57 and its Sortino ratio 0.99, versus 0.58 and 0.91 for the S&P 500.

ARMK’s 5‑year annualized volatility was 28.8%, higher than the S&P 500’s 17.0%, with a beta of 1.10.

Among large US stocks, the lowest correlations with ARMK over the last 60 months were REGN (−0.18), PFE (−0.02), ABBV (−0.01). Its correlation with long Treasuries (TLT) was 0.25 and with gold (GLD) 0.11.

ARMK beat the consensus earnings-per-share estimate in 9 of its last 12 quarterly reports through Aug 11, 2026, and the revenue estimate in 6 of 12. The stock moved 5.7% on average, up or down, from the close before each report to the close after it.

Yes. As of Oct 20, 2026, 6 members of Congress had disclosed 17 trades in ARMK (11 buys and 6 sales) in STOCK Act disclosures filed with the House and Senate.

As of the Sep 30, 2026 settlement date, 2.99% of ARMK’s float was sold short (7.8 million shares, 3.6 days to cover), according to FINRA short-interest reports. A year earlier it was 3.70%.

Yes. ARMK’s diluted share count rose 6.2% over the five fiscal years to fiscal 2025 and rose 0.4% in the latest year. Stock-based compensation was 0.3% of revenue, and buybacks totaled $140.2 million.

What do the best‑ranked analysts say on ARMK now?

Exent ranks Wall Street analysts by their track record. Gems shows who the top‑ranked analysts on ARMK are, their latest calls and the stocks where several of them agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.